Press Release
ERB Hub Launches California Honey Digital Art Collection, Elevating Relaxation and Creativity
Experience a New Era of Relaxation and Creativity with ERB Hub’s Exclusive California Honey Digital Art Collection
New Jersey, USA, 25th April 2025, ZEX PR WIRE, ERB Hub, the leader in merging CBD culture with cutting-edge digital art, proudly announces the launch of its highly anticipated California Honey Digital Art Collection. This groundbreaking collection combines the soothing power of California Honey products with stunning, high-quality digital artwork, creating a unique sensory and visual experience that enhances relaxation, creativity, and CBD appreciation.
For fans of California Honey, a brand known for its premium products, this new digital art collection offers an exciting way to enjoy the best of both worlds. The California Honey Digital Art Collection provides a visual interpretation of California Honey’s most sought-after offerings, delivering a mesmerizing and immersive experience that elevates the ritual of CBD consumption.
California Honey has long been synonymous with high-quality, innovative products, and now, ERB Hub is taking it one step further by blending art and wellness. Each piece of digital artwork is inspired by the essence of California Honey’s popular products, offering CBD enthusiasts and art lovers alike a fresh way to engage with their favorite items.
The California Honey Digital Art Collection features a diverse range of artworks, including representations of California Honey Edibles Digital Art, which captures the rich and flavorful experience of California Honey’s gummies and infused edibles. Flavors such as Watermelon Wave, Sour Apple, and Sour Strawberry come to life in vibrant digital art, reflecting the sweetness and tang of each flavor in an exciting new visual format.
For those who appreciate the smooth, calming effects of vaping, the California Honey 2G Vapes Digital Art collection is a must-see. These vivid digital representations of the California Honey vape flavors, like Pink Acai, Purple Punch, and Biscotti, showcase the unique profiles of each product, giving consumers a visual connection to their vaping experience. The California Honey Disposable Vape Digital Art collection also features eye-catching pieces, bringing flavors like Sour Diesel and Strawberry Cough to life in bold, graphic designs.
In addition to the vape and edible digital artwork, the California Honey collection also includes California Honey Live Resin Digital Art pieces, which celebrate the purity and potency of California Honey’s live resin products. These stunning visuals showcase the rich, golden hues of live resin extracts, elevating the aesthetic appeal of the collection and offering a deeper connection to the potency and quality of the products.
“ERB Hub is constantly looking for new ways to redefine the relationship between CBD products and digital art,” said a spokesperson for the company. “The California Honey Digital Art Collection is an exciting development that invites customers to immerse themselves in a visual experience that is as relaxing as the products themselves. We want to offer a sensory experience that goes beyond just consumption—this collection is about culture, art, and mindfulness.”
The California Honey Digital Art Collection offers more than just stunning visuals—it’s a celebration of relaxation and creative expression. For those who enjoy a calming pre-roll experience, the California Honey Pre Rolls Digital Art collection presents a visual tribute to the soothing ritual of smoking, featuring bold, detailed artwork inspired by California Honey’s most popular strains, including Skywalker OG and East Coast Sour Diesel. The California Honey Infused Blunts Digital Art collection takes this concept even further, showcasing the craftsmanship and artistry behind California Honey’s expertly rolled blunts.
As part of its commitment to providing customers with a holistic CBD experience, ERB Hub is also introducing exclusive digital artwork that complements essential California Honey accessories. The California Honey Vape Pen Digital Art features stunning representations of the brand’s sleek, high-performance vaping devices, marrying technology with creativity and offering a modern, artistic twist on functional products.
The California Honey Digital Art Collection is the latest in a series of innovative releases by ERB Hub, which has earned a reputation for blending high-quality CBD products with stunning digital art. Whether you’re a seasoned CBD user or a newcomer to the world of wellness, this collection offers a new way to experience the benefits of California Honey in a format that appeals to both the mind and the senses.
ERB Hub is committed to providing its customers with a seamless and enjoyable shopping experience. All products featured in the California Honey Digital Art Collection come with detailed descriptions, lab-tested information, and transparent pricing, so customers can make informed purchasing decisions. ERB Hub uses cutting-edge extraction techniques to ensure that each product meets the highest standards of quality and consistency.
Additionally, the ERB Hub website offers a complete shopping experience, with a user-friendly interface and dedicated sections for news, promotions, and FAQs. Customers can explore the California Honey Digital Art Collection, browse through a variety of other CBD products, and stay up to date with the latest industry trends and exclusive offers.
With this exciting new collection, ERB Hub is inviting consumers to experience the world of CBD in a completely new light. Whether you’re admiring the vibrant colors of California Honey Edibles Digital Art or getting lost in the rich details of California Honey Vape Digital Art, each piece is designed to enhance your appreciation for both the products and the artistry behind them.
ERB Hub is redefining relaxation and creativity with the California Honey Digital Art Collection—where CBD culture and digital art meet. Step into a new era of enjoyment and explore the future of CBD today.
About ERB Hub
Based in New Jersey, ERB Hub is a premier provider of digital art and CBD products, focused on delivering high-quality, creative, and customer-centric experiences. ERB Hub combines the best of both worlds—CBD culture and digital art—offering products that appeal to enthusiasts of wellness and creativity alike. Visit www.erb-hub.com to discover more and explore the full California Honey Digital Art Collection.
For additional information and business inquiries, please contact: https://erb-hub.com/
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
BioLight Launches BioLithin A Breakthrough Mitochondrial Supplement for Energy Muscle Health and Longevity
United States, 17th Sep 2025 – BioLight, an innovative leader in advanced health and longevity solutions, proudly announces the launch of BioLithin, a next-generation mitochondrial supplement designed to strengthen cellular resilience, boost energy, and support long-term vitality.
BioLithin is formulated with a unique combination of Urolithin A, Urolithin B, and Taurine, all carefully selected and dosed based on the latest scientific research. By targeting mitochondrial renewal and optimizing cellular function, BioLithin provides a powerful defense against the natural decline in energy, muscle health, and cognitive function that comes with aging.
A Revolutionary Approach to Mitochondrial Health
Mitochondria, often referred to as the “powerhouses” of the cell, play a vital role in energy production, metabolism, and longevity. As people age, mitochondrial efficiency declines, leading to fatigue, reduced strength, and increased vulnerability to age-related conditions. BioLithin was created to address this challenge directly, helping individuals renew their mitochondrial health from the inside out.
The supplement works through three core mechanisms:
- Mitochondrial Renewal – Promotes recycling and creation of new mitochondria, enhancing energy efficiency and endurance.
- Longevity Defense – Combats inflammation and oxidative damage, two of the biggest contributors to cellular aging.
- Neuroprotection – Activates brain-supportive pathways that help defend against cognitive decline and promote mental clarity.
A Synergistic Blend of Science-Backed Ingredients
What sets BioLithin apart is its groundbreaking combination of Urolithin A, Urolithin B, and Taurine:
- Urolithin A – Shown in clinical studies to support mitochondrial biogenesis and improve muscle endurance, making it a cornerstone in longevity science.
- Urolithin B – A rare, naturally occurring compound that complements Urolithin A, supporting muscle growth and protein synthesis.
- Taurine – A powerful amino acid linked to cellular hydration, heart health, and brain function, recently highlighted in longevity research as essential for healthy aging.
Unlike other supplements that use general extracts, BioLight sources ultra-high purity Urolithins from pomegranate peel—the most efficacious portion of the fruit for delivering these compounds. This ensures that every capsule of BioLithin offers unmatched potency and consistency.
Rooted in Cutting-Edge Research
Every ingredient and dosage in BioLithin is backed by the latest peer-reviewed science. Studies have demonstrated the profound effects of Urolithins on mitochondrial renewal, muscle health, and cognitive vitality. By combining these compounds with Taurine, BioLight has created a supplement that not only supports longevity but also empowers individuals to stay active, resilient, and mentally sharp as they age.
“With BioLithin, we’re taking mitochondrial health to the next level,” said Don Bailey, spokesperson for BioLight. “This product was designed for those who want to maintain peak energy, strength, and cognitive performance throughout their lives. We believe BioLithin represents a new frontier in longevity science, giving people the tools to age better, stronger, and smarter.”
Availability
BioLithin is now available exclusively through the BioLight official website. Customers can explore detailed product information, scientific references, and purchase options directly from the site.
About BioLight
Founded with a mission to advance human longevity through science-based nutrition, BioLight develops innovative supplements that target the root causes of cellular aging. By combining cutting-edge research with high-purity ingredients, BioLight is redefining what’s possible in proactive health and wellness. The company is committed to helping people achieve optimal vitality and resilience at every stage of life.
Media Contact
Organization: BioLight
Contact Person: Don Bailey
Website: https://www.biolight.shop/
Email: Send Email
Country:United States
Release id:34071
Disclaimer: This press release is for informational purposes only and does not constitute medical advice. The product described is a dietary supplement, not intended to diagnose, treat, cure, or prevent any disease. Individuals should consult a qualified healthcare professional before starting any new supplement regimen.
The post BioLight Launches BioLithin A Breakthrough Mitochondrial Supplement for Energy Muscle Health and Longevity appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Savitri Network Officially Launches and Opens Private Sale on September 15, 2025
Astana, Kazakhstan, 17th September 2025, ZEX PR WIRE, Savitri Network, a next-generation blockchain with a dual-token model, officially launched on September 15, 2025, at 12:00 PM UTC+0. The highly anticipated event introduces a unique and innovative approach to blockchain technology and also kicks off the private sale of the blockchain’s native token, $SAVI, giving crypto enthusiasts the opportunity to join the project in its early stages.
Savitri Network seamlessly combines artificial intelligence (AI), Internet of Things (IoT) capabilities, and governance convergence into a single, sustainable ecosystem, driving real-world adoption of blockchain technology. The project aims to go beyond the common use of blockchain networks, which are often focused primarily on financial transactions.
Savitri Network supports predictable, ultra-low transaction costs, seamless IoT data integration, and AI-powered services directly on-chain. These features expand its use cases beyond financial operations. As a result, the network has the potential to serve as the foundational operating layer for various real-world industries, including logistics, healthcare, and supply chain management.
Key features of Savitri Network include:
- Dynamic staking rewards that adjust over time (8% → 5% → 3%) to balance incentives and sustainability.
- Enterprise-ready design: A fixed transaction fee of $0.0035 per transaction, making blockchain integration viable at scale.
- High-speed performance: 230,000 transactions per second (TPS) with confirmation in just 836 milliseconds.
- Energy efficiency: Up to 95% lower energy consumption compared to most blockchains.
- Developer-friendly tools: Easy-to-use APIs and SDKs for seamless developer access.
- Broad technological support: Real-world interoperability between IoT devices, AI models, and enterprise systems.
One of Savitri Network’s most notable innovations is its dual-token model, centered around two robust tokens: $SAVI and $VOTE.
- The $SAVI coin is the backbone of the Savitri Network ecosystem. It is designed to power transactions, staking, AI model payments, and IoT services. With a total supply of 2 billion $SAVI coins and a 50-year emission model with adaptive deflation, $SAVI ensures both stability and longevity. Ten percent of the total supply is allocated to the private sale, which begins on launch day.
- The $VOTE token is built to enable transparent, community-driven governance. It allows holders to influence the network’s future and earn rewards by participating in governance processes. $VOTE uses a quadratic voting system and incorporates a deflationary burn mechanism that reduces supply over time.
Savitri Network employs Proof-of-Unity (PoU) as its consensus mechanism, designed for speed, fairness, and inclusivity. PoU ensures fast, low-cost, and eco-friendly validation without the need for mining, complex staking, or centralized authority. Instead, it encourages collaboration, minimizes energy waste, and promotes true decentralization.
The team behind Savitri Network emphasizes that it is building an innovative blockchain designed to last for the next 100 years, with a focus on real-world adoption and purpose-driven innovation.
Join the $SAVI Coin private sale and become part of the project at the very start of its promising journey. The event features structured vesting, ensuring investor protection and fostering long-term value creation for the token.
About Savitri Network
Savitri Network’s blockchain stands out with its infrastructure optimized for real-world enterprise adoption. The project appeals to crypto enthusiasts seeking ethical and scalable initiatives, as well as developers building on-chain, AI-driven, or IoT-based applications. In the future, Savitri Network aims to support enterprises and governments seeking traceability and ESG compliance.
The Savitri Network team encourages communities in emerging markets and forward-looking investors to join its purpose-driven infrastructure built for utility and longevity.
Learn more about Savitri Network on its official website and social media channels: X, Telegram, Discord, LinkedIn, Medium, and YouTube.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Open Doors to the Asian Market: Seoul Bio Hub-Celltrion Launches ‘Global Open Innovation’ for U.S. Startups
Seoul Bio Hub and Celltrion Launch Strategic Gateway ‘Global Open Innovation’ to Help U.S. Bio Startups Dominate the Asian Market
Two U.S.-Based Biotech and Medical Device Startups to Be Selected Based on Technology Alignment with Celltrion’s Expertise in Antibodies, Peptides, and Drug Formulation
Seoul, Korea – 17/09/2025 – (SeaPRwire) – Seoul’s bio startup hub ‘Seoul Bio Hub’ and global pharmaceutical leader ‘Celltrion’ have joined forces to launch the ‘2025 Seoul Bio Hub-Celltrion Global Open Innovation (GOI)’ program. This program goes beyond a simple competition, serving as a platform designed to help U.S. startups successfully establish themselves in the Asian market.
This GOI targets U.S.-based bio and medical startups, with companies established within the past 7 years eligible to apply. The recruitment areas encompass all technologies suitable for collaboration with Celltrion, including antibodies, peptides, small molecules, formulations, and cell and gene therapies.
The application deadline is September 30, 2025. The selection process will proceed in the following order:
- Primary document evaluation
- Technology review
- Secondary presentation evaluation.
The two finally selected companies will receive customized follow-up support and gain opportunities to expand into global markets through collaboration with Celltrion, leveraging South Korea’s innovative ecosystem and global capabilities.
A Seoul Bio Hub representative stated, “This program will serve as a bridgehead that goes beyond simple space support, enabling U.S. startups to rapidly grow in the Asian market by leveraging Seoul’s excellent clinical infrastructure and research environment.”
A Celltrion representative announced, “Based on Celltrion’s capabilities and know-how accumulated across the entire pharmaceutical industry process including R&D, production, and sales, we will support promising U.S. startups to successfully enter the Asian market and create synergy with our company.”
South Korea has established itself as a bio hub leading the global market with clear numerical evidence. According to global consulting firm Intralink, South Korea’s biopharmaceutical market is valued at approximately $22 billion, ranking 13th globally.
Additionally, market research firm Grand View Research forecasts that South Korea’s biotechnology market will grow to $81.6 billion (approximately 110 trillion KRW) by 2030, representing an annual average growth rate of 18.3%.
Private investment is also active. From 2020 to 2022, R&D and facility investments recorded an annual average growth rate of 21.6%. This demonstrates that South Korea is not merely a potential market, but a rapidly growing innovation ecosystem.
According to ClinicalTrials.gov, the global clinical trial database, Seoul has consistently maintained a top position among major global cities in the number of new clinical trials over the past decade.
South Korea’s Ministry of Health and Welfare has set ‘Achieving Global 3rd Place in Clinical Trials’ as a policy objective through the ‘3rd Five-Year Plan for the Pharmaceutical and Bio Industry (2023-2027)’. Furthermore, in 2025, it raised a total of over 386.6 billion KRW through the ‘Bio Health Mega Fund’ and is actively supporting innovative companies’ clinical trials and commercialization through the national integrated bio big data construction project and AI, bio health regulatory regulatory sandboxes.
Seoul Bio Hub is a bio startup support organization established by Seoul City in 2017. It provides 251 pieces of shared laboratory equipment and affordable tenant space at 10% of the cost compared to major areas in Seoul. As of May 2025, it has supported 322 startups and attracted a total of 576 billion KRW in follow-up investment, proving its potential for success.
Celltrion is South Korea’s global comprehensive biotechnology company that developed the world’s first antibody biosimilar ‘Remsima’. The company performs the entire process from research and development to approval, production, and sales, supplying high-quality biopharmaceuticals to over 100 countries worldwide. Based on world-class research and production infrastructure, it contributes to expanding global access to pharmaceuticals and continues to support and collaborate with promising startups through active open innovation strategies.
For detailed information regarding program applications and inquiries, please access LinkedIn, search for ‘Seoul Bio Hub’, and check the 「2025 Seoul Bio Hub-Celltrion Global Open Innovation」 recruitment announcement posted on the official company page.
About Seoul Bio Hub
https://www.seoulbiohub.kr/front/user/engmain.do
Establishment Date: October 30, 2017
Operating Entity: Established by Seoul City / Joint operation by KIST and Korea University
Location: 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea
Purpose: Growth and commercialization support for early-stage bio and healthcare startups under 10 years
Tenant Companies (As of June 2025): Total 126 companies (Digital Health 42 companies (33.3%), Pharmaceuticals 61 companies (48.5%), Medical Devices 23 companies (18.2%))
Infrastructure: Laboratories, office spaces, meeting rooms, conference rooms, research equipment (249 devices, 109 types, approximately $8 million scale)
Research and Human Resource Network (Regional): Approximately 7,000 PhD-level personnel, approximately 120,000 university students, $1.13 billion in research funding, connections with 12 universities and research institutions and 7 hospitals
Major Support Programs:
- IR matching and investment linkage
- Expert consulting and CEO education
- Hospital-linked clinical and data programs
- Open innovation with domestic and international pharmaceutical companies
About Celltrion
https://www.celltrion.com/en-us
Establishment Date: February 26, 2002
Location (Headquarters): 23 Academy-ro, Yeonsu-gu, Incheon Metropolitan City, Republic of Korea
Business Areas and Major Products (Services)
Possessing Differentiated Integrated Solutions Across the Entire Biopharmaceutical Business Process
- Remsima: World’s first monoclonal antibody biosimilar (TNF-α inhibitor)
- Herzuma: Trastuzumab biosimilar for breast and gastric cancer treatment
- Truxima (CT-P10): Rituximab biosimilar (lymphoma, rheumatoid arthritis, etc.)
- Multiple products including Zymfentra, Yuflyma, Vegzelma, Steqeyma, Avtozma are under global approval and commercialization
No of Employees: Approx. 3,003 (As of June 30, 2025)
Media Contact
Brand: SEOUL BIO HUB
Contact: Lee Yoon Jin
Phone: +82 02-2200-3345
Email: lynj@kist.re.kr
Website: (KOR) https://www.seoulbiohub.kr/front/user/main.do;
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
-
Press Release1 week ago
Talisman Brings Built-In Crypto AI Agents to the Wallet
-
Press Release7 days ago
Earn $7,700 a day: BJMINING revolutionizes Bitcoin passive income with cloud mining
-
Press Release2 days ago
Software Applications Launches All-in-One Business Management Platform to Simplify Operations for Businesses of All Sizes
-
Press Release1 week ago
Talisman Brings Built-In Crypto AI Agents to the Wallet
-
Press Release7 days ago
Swanson Reed Acquires AusGrant Strengthening Its Position as a Global Leader in R&D and Innovation Funding
-
Press Release7 days ago
How WinnerMining Makes Passive Income from BTC and XRP Simple and Transparent
-
Press Release4 days ago
More Than Metrics: Elliot Ambalo’s Blueprint for Long-Term Brand Loyalty
-
Press Release3 days ago
Rocketta Confirms September 19 Launch Date for Frontier Alpha ETF (in Strategic Deal with Altimor Asset Strategies), Investor Demand Surges Ahead of Trading Window